Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,566 results for ""Tegafur""

Your Filters

Subject : antineoplastic combined chemotherapy protocols
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).

  • Authors : Ogata Y; Department of Surgery, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, Fukuoka, 830-0011, Japan. .; Sadahiro S

Subjects: Tegafur*/Tegafur*/Tegafur*/administration & dosage ; Tegafur*/Tegafur*/Tegafur*/therapeutic use ; Uracil*/Uracil*/Uracil*/administration & dosage

  • Source: International journal of clinical oncology [Int J Clin Oncol] 2024 Sep; Vol. 29 (9), pp. 1284-1292. Date of Electronic Publication: 2024 Jun 04.Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer.

  • Authors : Morohashi H; Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi, Aomori, 036-8562, Japan. .; Sakamoto Y

Subjects: Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/therapy ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/pathology ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/mortality

  • Source: BMC gastroenterology [BMC Gastroenterol] 2024 Dec 18; Vol. 24 (1), pp. 456. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer.

  • Authors : Kashiwa M; Faculty of Pharmacy, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. .; Comprehensive Unit for Health Economic Evidence Review and Decision Support, Ritsumeikan University, Kyoto, Japan. .

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/economics ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use ; Cisplatin*/Cisplatin*/Cisplatin*/administration & dosage

  • Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Dec; Vol. 55 (4), pp. 1569-1580. Date of Electronic Publication: 2024 Aug 22.Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Short term efficacy and safety of PD-1 inhibitor and apatinib plus S-1 and oxaliplatin as neoadjuvant chemotherapy for patients with locally advanced gastric cancer.

  • Authors : Tang Y; Department of Gastrointestinal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.; Guizhou Medical University, Guiyang, Guizhou Province, China.

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy

  • Source: Medicine [Medicine (Baltimore)] 2024 Nov 15; Vol. 103 (46), pp. e40572.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.

  • Authors : Li Z; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.; Fan X

Subjects: Albumins*/Albumins*/Albumins*/administration & dosage ; Albumins*/Albumins*/Albumins*/therapeutic use ; Albumins*/Albumins*/Albumins*/pharmacology gemcitabine-oxaliplatin regimen

  • Source: The oncologist [Oncologist] 2024 Nov 04; Vol. 29 (11), pp. 997-e1614.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE).

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy

  • Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Nov 02; Vol. 54 (11), pp. 1214-1218.Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inetetamab combined with S-1 and oxaliplatin as first-line treatment for human epidermal growth factor receptor 2-positive gastric cancer.

  • Authors : Kong Y; Department of Oncology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.; Dong Q

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/mortality

  • Source: World journal of gastroenterology [World J Gastroenterol] 2024 Oct 28; Vol. 30 (40), pp. 4367-4375.Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study.

  • Authors : Tsai HJ; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/therapeutic use ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/administration & dosage ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacology

  • Source: The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. e1396-e1405.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study.

  • Authors : Jin M; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.; Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, People's Republic of China.

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/mortality

  • Source: The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. e1406-e1418.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Early Breast Cancer Treated with Adjuvant S-1 plus Endocrine Therapy-A Report of Two Cases].

  • Authors : Adachi K; Division of Breast and Endocrine Surgery, Dept. of Surgery, The Nippon Dental University Hospital.; Nagae J

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery

  • Source: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2024 Oct; Vol. 51 (10), pp. 1065-1067.Publisher: Gan To Kagaku Ryohosha Country of Publication: Japan NLM ID: 7810034 Publication Model: Print Cited Medium: Print ISSN: 0385-0684

Record details

Read More Add to Saved list
×
  • 1-10 of  3,566 results for ""Tegafur""